Midyear Symposium & Live Webcast
Overview
Patients with hemophilia who are acutely ill with bleeding issues or having surgery are a challenge in the hospital setting, and pharmacists can provide assistance in initiating therapy with hemostatic agents and play a key role in dosing, monitoring, and revising patient regimens. This educational activity will provide an overview of the epidemiology and pathophysiology of hemophilia and will outline various strategies for treatment of patients with hemophilia, specifically those with acute bleeding or planned surgery. Factors to consider when making formulary decisions regarding hemostatic agents will be presented. The activity will conclude with a discussion of patient scenarios illustrating innovative strategies for managing acute bleeding using available treatments in patients with hemophilia in the hospital setting.
Learning Objectives
After attending this application-based educational activity, participants should be able to
- Discuss the epidemiology and pathophysiology of various types of hemophilia.
- Examine the various pharmacologic approaches to the treatment of patients with hemophilia, including patient-specific factors to consider.
- Consider key factors when making formulary decisions on the selection of coagulation factors.
- Devise a plan for using laboratory values and physical signs to influence selection of available treatments in a patient with hemophilia.
- Monitor patients with hemophilia who are receiving hemostatic agents for acute bleeding for signs that bleeding is resolving.
- Discuss selected treatment strategies for patients requiring hemostatic agents.
Agenda
| 11:30 a.m. – 11:35 a.m. | Welcome William E. Dager, Pharm.D., BCPS (AQ-Cardiology) |
| 11:35 a.m. – 12:10 p.m. | Hemophilia and Bleeding Disorders Mark T. Reding, M.D. |
| 12:10 p.m. – 12:45 p.m. | Clinical Considerations in Managing Acute Bleeding in Patients with Hemophilia Surabhi Palkimas, Pharm.D. |
| 12:45 p.m. – 1:10 p.m | Patient Scenarios: Innovative Strategies for Managing Patients with Hemophilia in the Hospital Setting William E. Dager, Pharm.D., BCPS (AQ-Cardiology) |
| 1:10 p.m. – 1:30 p.m. | Faculty Discussion and Audience Questions All Faculty |
Faculty
William E. Dager, Pharm.D., BCPS (AQ-Cardiology), Activity Chair
Pharmacist Specialist
UC Davis Medical Center
Sacramento, California
William E. Dager, Pharm.D., BCPS (AQ-Cardiology), is a pharmacist specialist at UC Davis Medical Center in Sacramento, California, where he is responsible for managing challenging cases in anticoagulation, pharmacokinetics, and critical care. He also is clinically active with the cardiology service and serves as the director of the postgraduate year two (PGY-2) residency in cardiology at UC Davis. In addition, Dr. Dager holds three academic positions. He is Clinical Professor of Pharmacy at the University of California, San Francisco (UCSF) School of Pharmacy and Clinical Professor of Medicine at the University of California, Davis (UC Davis) School of Medicine. He also serves as Clinical Professor at the Touro School of Pharmacy in Vallejo, California.
Dr. Dager earned his Doctor of Pharmacy degree at UCSF and completed a residency at the UC Davis Medical Center in Sacramento. In addition, he completed the University of Pittsburgh Nephrology Pharmaceutical Care Preceptorship. He is a board-certified pharmacotherapy specialist and fellow of the American College of Clinical Pharmacy (ACCP), American Society of Health-System Pharmacists (ASHP), California Society of Hospital Pharmacists, and Society of Critical Care Medicine (SCCM).
Dr. Dager's research interests focus on anticoagulation, critical care medicine, cardiovascular disease, and pharmacokinetics and pharmacodynamics. He has authored numerous articles, book chapters, and scientific reviews, and he coauthored “Anticoagulation Therapy: A Point-of-care Guide” published by ASHP in 2011. He also regularly makes presentations at national and international educational conferences. Dr. Dager serves as a reviewer and editorial board member for several medical journals, and he currently is chair of the Editorial Advisory Board Panel on Anticoagulation for The Annals of Pharmacotherapy. He has served as a site coordinator for the ASHP Research and Education Foundation Antithrombotic Pharmacotherapy Traineeship. Dr. Dager has received multiple teaching and professional awards, including the 2008 ACCP Best Practice Award.
Surabhi Palkimas, Pharm.D.
Pharmacy Clinical Coordinator, Hematology
University of Virginia Health System
Charlottesville, Virginia
Surabhi Palkimas, Pharm.D., is Pharmacy Clinical Coordinator in Hematology at University of Virginia (UVA) Health System in Charlottesville, Virginia. In this role, she provides pharmacy services for the adult hematology inpatient consult team. Dr. Palkimas also serves as pharmacy chair of the Anticoagulation Committee and is an active member of the Patient Education and Communication Committee. In addition, she is a preceptor for the postgraduate year one (PGY-1) pharmacy residency and postgraduate year two (PGY-2) oncology residency at UVA Health System, both of which are accredited by the American Society of Health-System Pharmacists (ASHP).
Dr. Palkimas earned a Bachelor of Science degree in biochemical pharmacology from State University of New York at Buffalo and a Doctor of Pharmacy degree from Massachusetts College of Pharmacy & Health Sciences, Worcester Campus. She completed an ASHP-accredited PGY-1 pharmacy practice residency at Hospital of Saint Raphael in New Haven, Connecticut.
Dr. Palkimas is a member of ASHP, American College of Clinical Pharmacy, Virginia Pharmacists Association, and Anticoagulation Forum. In addition, she serves as a peer reviewer for The Annals of Pharmacotherapy. In addition, she serves as a peer reviewer for The Annals of Pharmacotherapy.
Mark T. Reding, M.D.
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center, Fairview
Associate Professor
University of Minnesota Medical School
Minneapolis, Minnesota
Mark T. Reding, M.D., is Director of the Center for Bleeding and Clotting Disorders at University of Minnesota Medical Center in Minneapolis. In this role he is responsible for providing and coordinating patient care in the clinic and hospital for all adult patients followed by the Center, which is a hemophilia treatment center supported by the Centers for Disease Control and Prevention. Dr. Reding also serves as Medial Director of the Inpatient Hematology/Oncology Unit at University of Minnesota Medical Center. In addition, he is Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota.
Dr. Reding received his Bachelor of Science degree in microbiology and biology at South Dakota State University in Brookings. He then earned a Doctor of Medicine degree at University of Minnesota Medical School in Minneapolis. He is board certified in hematology.
Dr. Reding’s clinical interest is the treatment of non-malignant hematologic disorders with particular emphasis on disorders of hemostasis and thrombosis, including hemophilia. His current research efforts focus on the immune response to factor VIII, the cellular mechanisms involved in the synthesis of factor VIII inhibitors, and the immunologic consequences of gene therapy. He has also served as the local principal investigator for multi-center clinical trials. His research has been published in peer-reviewed journals.
Dr. Reding considers teaching to be the most important and rewarding aspect of his work, and he twice was awarded the Outstanding Clinical Mentor Award from his division at the Medical School. In addition to teaching responsibilities at the University, he frequently speaks at educational programs for physicians and other health care professionals.
Dr. Reding is a member of American Society of Hematology, Hemostasis and Thrombosis Research Society (HTRS), and International Society for Thrombosis and Hemostasis. He recently completed a two-year term on the board of directors for HTRS.
Continuing Education Information
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #0204-0000-12-446-LO1-P).
Attendees must complete a Continuing Pharmacy Education Request online and may immediately print their official statements of continuing pharmacy education credit at the ASHP CE Center at http://ce.ashp.org following the activity.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, and it would be particularly beneficial for pharmacists, clinical specialists, pharmacy managers, leaders, and educators who are interested in emergency medicine, critical care, coagulation factors, emerging therapies, hemophilia, hemostasis, patient safety, and formulary management.
Onsite Information
There is no registration for this Midday Symposium. Seating at this activity is on a first-come, first-served basis. Please plan to arrive early. There is no fee to attend this continuing education activity. A map of the floor plan with the location of the Midday Symposium highlighted is available as PDF download.
Arrangements for Special Assistance
If you have any disability for which you may require an auxiliary aid or special service while participating in this activity, please contact support@ashpadvantage.com.
Webcast Registration
This symposium will be broadcast live from Las Vegas, Nevada, as a webcast so that pharmacists unable to attend this year’s ASHP Midyear Clinical Meeting can participate.
Register for WebcastAfter registration, you will receive an e-mail confirmation with instructions for joining the webcast.
Download HandoutWebcast Information
What is a live webcast?
A live webcast brings the presentation to you – at your work place or in your home. You view and hear the presentations in “real time” complete with slides and video of the speakers and have the opportunity to ask questions at the end of the activity. Continuing pharmacy education (CPE) credits earned through participation in webcasts qualify as live CPE credit. Please join the webcast at least 5 minutes before the scheduled start time for important activity announcements.
How do I register?
Click the Register for Webcast button.
How do I process my CPE?
After completion of this webcast, you will process your CPE online and print your statement of credit at http://ce.ashp.org. You will need the Activity and Session Codes that will be announced at the end of the webcast. Complete CPE processing instructions will be included in your handout. If you have questions about processing CPE online, contact support@ashpadvantage.com.
What if I would like to arrange for my colleagues to participate in this webcast as a group?
One person should register for the webcast and will receive the webcast linking instructions via email. Each participant processes his or her CPE statement online at the conclusion of the activity.
How do I ask a question of the presenters during the webcast?
Click the “Ask a Question” bubble icon 
to type a question and your email. The speakers will answer as many questions as possible at the conclusion of the activity. Responses to technical questions will be sent to the email address you provided.
Why doesn’t the presentation appear?
If you’re using a pop-up blocker, configure it to allow this site’s pop-ups. You will need to change settings in your browser.
Why can’t I hear audio?
Check your volume controls and whether the device you are using has speakers. There are three areas you may find volume controls:
- Player volume: look for volume icon inside the player.
- Adjust the volume slider and confirm that mute is not selected.
- External speakers (optional): check whether the speakers have a volume control dial or knob that you can use to increase or decrease the volume level.
What if my video frame keeps freezing, progressing a bit, and then freezing again?
Depending on the speed of your internet connection, there may not be enough bandwidth to accommodate the audio, slides, and live video. To alleviate this, either minimize or turn off the video by using the icons on your screen. You can also use the Classic Player version of the webcast tool to achieve better viewing.
What do I need to participate in the webcast?
For the best presentation viewing experience, we recommend a broadband internet or Wi-Fi connection and the following system requirements:
| Microsoft® Windows® | Mac® | Linux |
|
|
|
*If Silverlight is not detected on your computer when viewing a presentation, you will be automatically prompted to install the plug-in. Silverlight only needs to be installed once and will then be available for watching any other presentations.
Classic Player Option
If you are unable to install Silverlight or your bandwidth speed is slower than required, another version of the webcast is available. The requirements are as follows:
| Microsoft® Windows® | Mac® | Linux |
|
|
|
* If Silverlight is not detected on your computer when viewing a presentation, you will be automatically prompted to install the plug-in. Silverlight only needs to be installed once and will then be available for watching any other presentations.
| iPad | iPhone and iPod | Android | BlackBerry |
|
|
|
|